CO regulation of hypothalamic neuronal activity in health and disease states

健康和疾病状态下丘脑神经元活动的 CO 调节

基本信息

  • 批准号:
    8282375
  • 负责人:
  • 金额:
    $ 22.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-04-16 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): While coordinated activities of the sympathetic and neuroendocrine systems are essential for proper maintenance of bodily homeostasis, sustained sympathohumoral activation is highly detrimental, contributing to several prevalent diseases, including heart failure (HF). Despite this evidence, a comprehensive understanding of the basic mechanisms underlying neurohumoral responses both in physiological and pathological conditions is still missing. The hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei play pivotal roles in the generation of sympathohumoral responses, and accumulating evidence supports elevated neuronal activity in these nuclei in animal models of HF. However, the precise underlying mechanisms remain incompletely understood. The atypical gas neurotransmitters, particularly nitric oxide (NO), are recognized as critical inhibitory signaling molecules in the brain, mostly in areas involved in autonomic/neuroendocrine integration. In fact, a blunted NO function has been shown to contribute to sympathohumoral activation in HF. Here, we propose the gas molecule carbon monoxide (CO) as a novel signaling mechanism within the SON/PVN. We obtained preliminary results showing that in opposition to NO, CO stimulates hypothalamic neuronal function. Thus, we put forward the novel concept that a balance between two opposing gas molecules is critical in determining neurohumoral outflows from the hypothalamus. Using a multidisciplinary approach combining in vitro electrophysiology, cell imaging, tract tracing and immunohistochemistry, we will test the central hypothesis that elevated CO bioavailability contributes to exacerbated SON/PVN neuronal activity in HF, and that these effects are mediated by blunting NO inhibitory function. We will test our central hypothesis in 2 specific aims: 1 - To determine the specific cellular sources of CO within the SON/PVN in sham and HF rats. Our working hypothesis is that the CO-synthetizing enzyme heme-oxygenase (HO) is expressed in specific cell populations within the SON/PVN, and that an elevated expression occurs in HF rats. 2 - To determine the cellular targets and mechanisms of action of CO within the SON/PVN in sham and HF rats. Our working hypothesis is that CO is an excitatory gas molecule targeting both neurosecretory and presympathetic neurons. We expect results from this R21 proposal to provide the proof-of-concept that CO is endogenously produced within the SON and PVN, and that it is a functionally relevant gas molecule influencing neuronal activity in these brain regions. We will begin to understand how changes in CO/NO interactions contribute to altered neuronal activity, and consequently neurohumoral output in an animal model of HF. We believe this knowledge will broaden our understanding of basic cellular mechanisms contributing to the hypothalamic control of homeostasis, as well as how changes in these mechanisms lead to pathological process in prevalent human diseases. PUBLIC HEALTH RELEVANCE: Heart failure, a major public health problem in the USA, is characterized by increased activity of the neuroendocrine and autonomic systems (neurohumoral activation), which strongly influences morbidity and mortality in these patients. However, the precise mechanisms underlying neurohumoral remain unknown. In this proposal, we will use a multidisciplinary approach to test a series of novel hypothesis that aim to elucidate signaling mechanisms within the central nervous system that contribute to neurohumoral activation in heart failure. We expect our work to provide novel information on mechanisms underlying altered neuronal function in heart failure patients, and to help in the development of novel and more efficient therapeutic strategies for the treatment of this prevalent disease.
描述(由申请人提供):虽然交感神经和神经内分泌系统的协调活动对于适当维持身体内稳态至关重要,但持续的交感神经体液激活是非常有害的,会导致包括心力衰竭(HF)在内的几种流行疾病。尽管有这些证据,但对生理和病理条件下神经体液反应的基本机制的全面理解仍然缺失。下丘脑室旁核(PVN)和视上核(SON)在交感体液反应的产生中起关键作用,越来越多的证据支持HF动物模型中这些核的神经元活性升高。然而,确切的潜在机制仍然不完全清楚。非典型气体神经递质,特别是一氧化氮(NO),被认为是大脑中重要的抑制信号分子,主要涉及自主神经/神经内分泌整合的区域。事实上,一氧化氮功能减弱已被证明有助于HF的交感病理体液激活。在这里,我们提出气体分子一氧化碳(CO)作为SON/PVN内的一种新的信号传导机制。我们获得的初步结果表明,与NO相反,CO刺激下丘脑神经元功能。因此,我们提出了一个新的概念,即两种相反气体分子之间的平衡是决定下丘脑神经体液流出的关键。采用多学科方法,结合体外电生理学、细胞成像、通道示踪和免疫组织化学,我们将验证CO生物利用度升高导致HF中SON/PVN神经元活性加剧的中心假设,并且这些影响是通过钝化NO抑制功能介导的。我们将在两个特定目标中验证我们的中心假设:1 -确定假手术和心衰大鼠SON/PVN内CO的特定细胞来源。我们的工作假设是co合成酶血红素加氧酶(HO)在SON/PVN内的特定细胞群中表达,并且在HF大鼠中表达升高。2 -确定CO在假手术和心衰大鼠SON/PVN内的细胞靶点和作用机制。我们的工作假设是CO是一种兴奋性气体分子,针对神经分泌和前交感神经元。我们期望这项R21提案的结果能够提供CO在SON和PVN内内源性产生的概念证明,并且它是一种影响这些大脑区域神经元活动的功能相关气体分子。我们将开始了解CO/NO相互作用的变化如何导致HF动物模型中神经元活动的改变,从而导致神经体液输出的改变。我们相信这些知识将扩大我们对下丘脑控制体内平衡的基本细胞机制的理解,以及这些机制的变化如何导致流行人类疾病的病理过程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Javier E Stern其他文献

Javier E Stern的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Javier E Stern', 18)}}的其他基金

Novel SCN-OVLT portal system: Dissecting Anatomical and Functional Properties
新型 SCN-OVLT 门户系统:剖析解剖和功能特性
  • 批准号:
    10754088
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
DENDRITIC RELEASE OF NEUROPEPTIDES: ROLE IN BODILY HOMEOSTASIS
神经肽的树突释放:在身体稳态中的作用
  • 批准号:
    9618919
  • 财政年份:
    2018
  • 资助金额:
    $ 22.46万
  • 项目类别:
DENDRITIC RELEASE OF NEUROPEPTIDES: ROLE IN BODILY HOMEOSTASIS
神经肽的树突释放:在身体稳态中的作用
  • 批准号:
    9769162
  • 财政年份:
    2018
  • 资助金额:
    $ 22.46万
  • 项目类别:
Central neuronal-glial mechanisms and neurohumoral activation in hypertension
高血压的中枢神经元神经胶质机制和神经体液激活
  • 批准号:
    8373050
  • 财政年份:
    2012
  • 资助金额:
    $ 22.46万
  • 项目类别:
Central neuronal-glial mechanisms and neurohumoral activation in hypertension
高血压的中枢神经元神经胶质机制和神经体液激活
  • 批准号:
    8669816
  • 财政年份:
    2012
  • 资助金额:
    $ 22.46万
  • 项目类别:
CO regulation of hypothalamic neuronal activity in health and disease states
健康和疾病状态下丘脑神经元活动的 CO 调节
  • 批准号:
    8458529
  • 财政年份:
    2012
  • 资助金额:
    $ 22.46万
  • 项目类别:
Central neuronal-glial mechanisms and neurohumoral activation in hypertension
高血压的中枢神经元神经胶质机制和神经体液激活
  • 批准号:
    8477277
  • 财政年份:
    2012
  • 资助金额:
    $ 22.46万
  • 项目类别:
CENTRAL NEURONAL-GLIAL MECHANISMS AND NEUROHUMORAL ACTIVATION IN HYPERTENSION
高血压的中枢神经元神经胶质机制和神经体液激活
  • 批准号:
    9618915
  • 财政年份:
    2012
  • 资助金额:
    $ 22.46万
  • 项目类别:
Altered CNS intercellular signaling mechanisms in cardiovascular disease
心血管疾病中中枢神经系统细胞间信号传导机制的改变
  • 批准号:
    8011516
  • 财政年份:
    2008
  • 资助金额:
    $ 22.46万
  • 项目类别:
Altered CNS Intercellular Signaling Mechanisms in Cardiovascular Disease
心血管疾病中中枢神经系统细胞间信号传导机制的改变
  • 批准号:
    9084606
  • 财政年份:
    2008
  • 资助金额:
    $ 22.46万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了